Spasmodic dysphonia is a rare neurological disorder that causes involuntary spasms in the vocal cords, making speech strained ...

Despite focused efforts to improve the diversity of clinical trials, representation in research into head and neck cancer has become less equitable over the past decade, according to retrospective ...

Q. I saw the news recently that the Food and Drug Administration is proposing to remove a popular ingredient in ...

23 in JAMA Otolaryngology-Head & Neck Surgery. Juan P. Brito, M.D., from the Mayo Clinic in Rochester, Minnesota, and ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

We've added an exciting new feature to our website. Click on "Clinical" in the navbar to explore!

Spasmodic dysphonia impacts about 50,000 people in North America. Here's what to know about what causes spasmodic dysphonia ...

LSU Health Shreveport Otolaryngology-Head and Neck Surgery residents earned top honors at The Triological Society’s 2025 ...

Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor ...

A new study links heavy cannabis use to head and neck cancer. Learn about the risks, research findings, and prevention ...

When a nosebleed hits, we often go into panic mode. We frantically reach for tissues and may try shoving them up in our ...